Showing results (511-520 of 626) with videos related to

Sort By:
Pageof 63
Science Advances|September 3, 2025
Ultrastrong Staphylococcus aureus adhesion to human skin: Calcium as a key regulator of noncovalent interactionsConstance Chantraine, Priscila S F C Gomes, Marion Mathelié-Guinlet, et al.
Dermatology and Therapy|July 30, 2026
Achieving Minimal Disease Activity in Atopic Dermatitis Is Associated with Fewer Flares, Reduced Healthcare Resource Utilization, and Improved Disease Control: Analysis from the Real-World MEASURE-AD StudyJonathan I Silverberg, Vimal H Prajapati, Susanne Abraham, et al.
The British Journal of Dermatology|September 3, 2017
Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statementA M Drucker, K Eyerich, M S de Bruin-Weller, et al.
The Journal of Allergy and Clinical Immunology|July 13, 2010
Raman profiles of the stratum corneum define 3 filaggrin genotype-determined atopic dermatitis endophenotypesGráinne M O'Regan, Patrick M J H Kemperman, Aileen Sandilands, et al.
Plos One|December 17, 2011
Development of allele-specific therapeutic siRNA in Meesmann epithelial corneal dystrophyHaihui Liao, Alan D Irvine, Caroline J Macewen, et al.
Development (Cambridge, England)|July 31, 2019
Dchs1-Fat4 regulation of osteogenic differentiation in mouseIvan Crespo-Enriquez, Tina Hodgson, Sana Zakaria, et al.
Dermatology and Therapy|June 18, 2026
Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)Emma Guttman-Yassky, Alan D Irvine, Melinda Gooderham, et al.
The British Journal of Dermatology|May 5, 2018
A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT)A D Irvine, A P Jones, P Beattie, et al.
The British Journal of Dermatology|January 7, 2022
Children with atopic dermatitis show increased activity of β-glucocerebrosidase and stratum corneum levels of glucosylcholesterol that are strongly related to the local cytokine milieuSanja Kezic, Maeve A McAleer, Ivone Jakasa, et al.
RMD Open|February 8, 2023
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitisGerd R Burmester, Stanley B Cohen, Kevin L Winthrop, et al.
Pageof 63